AM
Insider selling
Atabak Mokari sold $9.2M of Corcept Therapeutics Inc (CORT) stock
Atabak Mokari, Chief Financial Officer of Corcept Therapeutics Inc (CORT), sold 80,000 shares of CORT stock worth $9.2M, per an SEC Form 4 filed Aug 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 30, 2026, 4 days before it was made public.
CORT has moved -3.9% since the trade date, from $118.32 to $113.76 (Sep 21, 2026 close).
- Traded
- Jul 30, 2026
- Disclosed
- Aug 3, 2026
- Filing delay
- 4 days
- Price since
- -3.9%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More CORT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.